** Shares of Kaiser Permanente-backed healthcare startup CAMP4 Therapeutics rise 1.45% above their initial public offering price in co's market debut
** CAMP last up ~1% at $11.11; stock opened trading at $11.16 vs IPO price of $11
** With the rise in shares, CAMP is now valued a $197.37 mln
** Co raised $75 mln by selling 6.82 mln shares priced at $11 apiece, lower than its marketed range of $14 to $16
** J.P. Morgan, Leerink Partners, Piper Sandler and William Blair were the underwriters for the IPO
(Reporting by Prakhar Srivastava in Bengaluru)
((Prakhar.srivastava2@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.